Issue Date: May 17, 2010
Takeda, Pfizer Set Layoffs
Takeda Pharmaceutical will eliminate nearly 1,600 jobs in its North American operation. The Japanese company says it is taking the action to better align its size with its drug portfolio, which is challenged by delays in the development of new products and the 2012 onset of generic competition for Actos, its top-selling product in the U.S. Actos, a diabetes treatment, generated $3.2 billion in sales in the Americas last year. The company has . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society